JPS6058071A - Preparation of immobilized mold of microorganism or enzyme - Google Patents
Preparation of immobilized mold of microorganism or enzymeInfo
- Publication number
- JPS6058071A JPS6058071A JP16516783A JP16516783A JPS6058071A JP S6058071 A JPS6058071 A JP S6058071A JP 16516783 A JP16516783 A JP 16516783A JP 16516783 A JP16516783 A JP 16516783A JP S6058071 A JPS6058071 A JP S6058071A
- Authority
- JP
- Japan
- Prior art keywords
- enzymes
- enzyme
- solution
- microbial cells
- immobilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 73
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 73
- 244000005700 microbiome Species 0.000 title abstract description 13
- 239000000243 solution Substances 0.000 claims abstract description 31
- 239000000499 gel Substances 0.000 claims abstract description 30
- 108010010803 Gelatin Proteins 0.000 claims abstract description 22
- 239000008273 gelatin Substances 0.000 claims abstract description 22
- 229920000159 gelatin Polymers 0.000 claims abstract description 22
- 235000019322 gelatine Nutrition 0.000 claims abstract description 22
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 22
- 229920001864 tannin Polymers 0.000 claims abstract description 19
- 239000001648 tannin Substances 0.000 claims abstract description 19
- 235000018553 tannin Nutrition 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000000679 carrageenan Substances 0.000 claims abstract description 18
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 18
- 229920001525 carrageenan Polymers 0.000 claims abstract description 18
- 229940113118 carrageenan Drugs 0.000 claims abstract description 18
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 18
- 229920001817 Agar Polymers 0.000 claims abstract description 16
- 239000008272 agar Substances 0.000 claims abstract description 16
- 235000010419 agar Nutrition 0.000 claims abstract description 16
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 11
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- 239000007853 buffer solution Substances 0.000 claims abstract description 8
- 239000000110 cooling liquid Substances 0.000 claims abstract description 7
- 238000005507 spraying Methods 0.000 claims abstract description 4
- 230000000813 microbial effect Effects 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 21
- 239000002585 base Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 11
- 239000007921 spray Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 239000010775 animal oil Substances 0.000 claims description 3
- 239000002480 mineral oil Substances 0.000 claims description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 239000000758 substrate Substances 0.000 abstract description 13
- 238000002156 mixing Methods 0.000 abstract description 11
- 238000010438 heat treatment Methods 0.000 abstract description 10
- 238000001816 cooling Methods 0.000 abstract description 4
- 239000011259 mixed solution Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 58
- 210000004027 cell Anatomy 0.000 description 16
- 108010093096 Immobilized Enzymes Proteins 0.000 description 14
- 102000002704 Leucyl aminopeptidase Human genes 0.000 description 11
- 108010004098 Leucyl aminopeptidase Proteins 0.000 description 11
- 239000000203 mixture Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 210000005253 yeast cell Anatomy 0.000 description 8
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 7
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 7
- 239000007983 Tris buffer Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 6
- 108010046334 Urease Proteins 0.000 description 5
- 239000008351 acetate buffer Substances 0.000 description 5
- 239000007863 gel particle Substances 0.000 description 5
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 4
- 235000005687 corn oil Nutrition 0.000 description 4
- 239000002285 corn oil Substances 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000003028 enzyme activity measurement method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- -1 pimeridialdehyde Chemical compound 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AXZJHDNQDSVIDR-NSHDSACASA-N 4178-93-2 Chemical compound CC(C)C[C@H](N)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 AXZJHDNQDSVIDR-NSHDSACASA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 108030001819 D-glutamyltransferases Proteins 0.000 description 1
- 229920002085 Dialdehyde starch Polymers 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 108010036781 Fumarate Hydratase Proteins 0.000 description 1
- 102100036160 Fumarate hydratase, mitochondrial Human genes 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010036164 Glutathione synthase Proteins 0.000 description 1
- 102100034294 Glutathione synthetase Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 108030003379 NAD(+) synthases Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920001744 Polyaldehyde Polymers 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108091000100 Tyrosine Phenol-Lyase Proteins 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 108700040099 Xylose isomerases Proteins 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000012809 cooling fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 150000001913 cyanates Chemical class 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 108010010779 glutamine-pyruvate aminotransferase Proteins 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 108010003007 mannose isomerase Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- BHTJEPVNHUUIPV-UHFFFAOYSA-N pentanedial;hydrate Chemical compound O.O=CCCCC=O BHTJEPVNHUUIPV-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000010723 turbine oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は固定化された微生物菌体もしくは酵素の製造法
妃関し、その目的とするところは、基質との反応効率が
著しく高められた固定化された微生物菌体もしくは酵素
のゲルを得ることにある。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing immobilized microbial cells or enzymes, and its object is to produce immobilized microbial cells or enzymes that have significantly increased reaction efficiency with a substrate. The purpose is to obtain an enzyme gel.
従来、微生物、酵素等をカラギーナン、寒天もしくはゼ
ラチン等で包括固定化する方法は、固定化に際し活性の
低下が起り難(、又食品衛生上安全な方法として近年食
品、医薬工業への応用が試みられている。Conventionally, the method of comprehensively immobilizing microorganisms, enzymes, etc. with carrageenan, agar, gelatin, etc. has been difficult to reduce activity during immobilization (and in recent years, attempts have been made to apply it to the food and pharmaceutical industries as a safe method from a food hygiene perspective). It is being
そして通常、微生物菌体もしくは酵素をカラギーナン、
寒天もしくはゼラチン等のゲル基材で包括固定化する場
合、これらのゲル基材を加熱溶解したものに該微生物菌
体もしくは酵素を懸濁したものを、冷却液中に注射器も
しくは多孔板等より滴下もしくは流下させることにより
、球状もしくは糸状のゲルに成型されている。その際、
ゲル粒子径の調整は、一般に滴下の流速を調節すること
により行なわれているが、これらのゲル基材を含有する
液は粘度が高(、又液滴は液体の表面張力と重力とのバ
ランスにより形成されるため1滴下に使用されるノズル
の外径より大きい粒子径のものしか成型することが出来
ない。かぐして、従来は一2勧〜!副程度の粒子径のも
のが得られてりる〇又ゲル包括法により固定化された微
生物もしくは酵素を用いて酵素反応を行なう場合、該酵
素反応を効率的に行なわせるには、該固定化ゲル中へ基
質を充分透過させることが極めて重要である。Usually, microbial cells or enzymes are combined with carrageenan,
When entrapping immobilization with a gel base material such as agar or gelatin, the microorganisms or enzymes are suspended in a heated solution of the gel base material, and then dripped into the cooling liquid using a syringe or a perforated plate. Alternatively, it is formed into a spherical or thread-like gel by flowing down. that time,
Gel particle size is generally adjusted by adjusting the droplet flow rate, but liquids containing these gel base materials have a high viscosity (and the droplets are difficult to balance between the surface tension of the liquid and gravity). Because of this, it is only possible to form particles with a particle size larger than the outer diameter of the nozzle used to dispense one drop. Conventionally, particles with a particle size of about 12 mm to 12 mm can be formed. 〇Also, when performing an enzyme reaction using microorganisms or enzymes immobilized by the gel entrapment method, in order to perform the enzyme reaction efficiently, it is necessary to sufficiently permeate the substrate into the immobilization gel. extremely important.
この際、該ゲルは基質の移動に対し抵抗(拡散抵抗)を
示すため、ゲル粒子径の小さいもの程反応効率が高く、
又固定化微生物を用いる場合、従来の粒子径の大きいゲ
ル内の微生物はゲル表面の近辺で増殖し易−f−(、該
酵素反応はゲルの表層近辺にしか寄与されない(福井等
編「酵素工学」第3gg〜3り!頁、東京化学同人社発
行)等の理由で。At this time, since the gel exhibits resistance (diffusion resistance) to the movement of the substrate, the smaller the gel particle size, the higher the reaction efficiency.
Furthermore, when using immobilized microorganisms, the microorganisms in conventional gels with large particle diameters tend to proliferate near the gel surface. Engineering, pp. 3gg-3ri!, published by Tokyo Kagaku Dojinsha), etc.
反応効率を高めるには物質移動距離を短か(し、ゲル粒
子を微小化し、それに伴いゲルの表面積を増加させるこ
とが望まれている。In order to increase the reaction efficiency, it is desired to shorten the mass transfer distance, make the gel particles smaller, and increase the surface area of the gel accordingly.
一方、マイクロカプセル法により微生物菌体もしくは酵
素を固定化した場合、微小粒子の成型は可能であるが、
このような成型操作が煩雑であることの他、モノマー、
重合触媒もしくは有機溶剤等を使用するため、活性を著
しく低下させる等の欠点がある。On the other hand, when microbial cells or enzymes are immobilized using the microcapsule method, it is possible to form microparticles;
In addition to the complicated molding operation, the monomer,
Since a polymerization catalyst or an organic solvent is used, there are drawbacks such as a significant decrease in activity.
本発明は、このような従来技術の欠点を解消し。The present invention eliminates these drawbacks of the prior art.
固定化された微生物菌体もしくは酵素のゲル粒子径を微
小とし、基質との反応効率の著しく高められた固定化ゲ
ルを容易に得ることができるようにしたものである。The gel particle size of the immobilized microorganisms or enzymes is made minute, so that it is possible to easily obtain an immobilized gel with significantly increased reaction efficiency with the substrate.
即ち1本発明は微生物菌体、酵素をタンニンもしくは多
官能性架橋試薬で不溶化したもの、又は酵素を不溶化担
体に吸着したものを、そのまま。Specifically, the present invention uses microbial cells, enzymes insolubilized with tannins or polyfunctional crosslinking reagents, or enzymes adsorbed onto an insolubilized carrier, as they are.
或はこれらを水、または緩衝液、もしくは親水性有機溶
媒に懸濁したものを、水、または緩衝液、もしくは親水
性有機溶媒にゲル基材としてカラギーナン、寒天、もし
くはゼラチンを加熱溶解した液と、ゲル基材が固化せず
、かつ微生物菌体もしくは酵素が死滅もしくは失活しな
い温度で混合し−た液を、冷却液と噴霧接触させ微小ゲ
ルとすることを特徴とする固定化された微生物菌体もし
くは酵素の製造法である。Alternatively, these can be suspended in water, a buffer solution, or a hydrophilic organic solvent, and a solution prepared by heating and dissolving carrageenan, agar, or gelatin as a gel base in water, a buffer solution, or a hydrophilic organic solvent. , an immobilized microorganism characterized in that a liquid mixed at a temperature that does not solidify the gel base material and do not kill or deactivate the microorganism cells or enzymes is sprayed into contact with a cooling liquid to form a microgel. This is a method for producing bacterial cells or enzymes.
以下1本発明について詳述する。The present invention will be explained in detail below.
先ず1本発明忙用いられる微生物菌体としては、細菌、
酵母、黴、放線菌等、如何なる種別の菌体でも良い0又
酵素も如何なる種別のものでも良く、例えばアルコール
脱水素酵素、グルコースオキシダーゼ、乳酸脱水素酵素
等の酸化還元酵素、D−グルタミルトランスフェラーゼ
、グルタミントランスアミネース、ヘキンキナーゼ等の
転移酵素、ロイシンアミノペプチダーゼ、カルボキシペ
プチダーゼ、ペプチダ−ゼ等の加水分解酵素、フマラー
ゼ、アスパルターゼ、β−チロシナーゼ等のリアーゼ酵
素、グルコースイソメラーゼ、マンノースイソメラーゼ
等の異性化酵素、グルタチオンシンターゼ、NADシン
ターゼ等のりガーゼ酵素等が代表例として挙げられる0
上記した酵素は、タンニンもしくは多官能性架橋試薬で
不溶化させるか、又は該酵素を不溶化担体に吸着させる
。First, the microorganisms used in the present invention include bacteria,
The enzyme may be of any type, such as yeast, mold, actinomycetes, etc., and may be of any type, for example, oxidoreductases such as alcohol dehydrogenase, glucose oxidase, lactate dehydrogenase, D-glutamyl transferase, Transferases such as glutamine transaminase and hekin kinase, hydrolytic enzymes such as leucine aminopeptidase, carboxypeptidase, and peptidase, lyase enzymes such as fumarase, aspartase, and β-tyrosinase, and isomerase enzymes such as glucose isomerase and mannose isomerase. Representative examples include gauze enzymes such as , glutathione synthase, and NAD synthase. The above-mentioned enzymes are insolubilized with tannin or a polyfunctional crosslinking reagent, or the enzymes are adsorbed onto an insolubilized carrier.
先ず、タンニンで不溶化させる場合は、酵素量に対し/
−10倍量cW/W)のタンニンを含有する溶液を加え
、pHざ以下、好ましくはpHJ〜7で攪拌しつつ反応
させ、得られた酵素沈澱物より例えば遠心分離、濾過等
の通常の分離手段を用いて不溶化酵素を得る0
なお上記タンニンとしては、タンニン酸の他。First, when insolubilizing with tannin, the amount of enzyme should be
- Add a solution containing tannin (10 times the amount cW/W), react with stirring at pH below, preferably pHJ ~ 7, and separate the resulting enzyme precipitate by conventional separation such as centrifugation or filtration. Obtaining an insolubilized enzyme using means 0 Note that the above-mentioned tannins include tannic acid.
ピロガロールタンニン例えば没食子タンニン又は五倍子
タンニン、カテコールタンニン例えハ茶。Pyrogallol tannins such as gallic tannins or pentadol tannins, catechol tannins such as hacha tea.
カカオ等から得られるタンニン質分(カテコール重合体
)等が用いられる。これらのタンニンはタンニン作用を
有する限り精製されていないものでも良(、例えば市販
の柿渋タンニン等も用いられる。これらは単独でも一種
以上のタンニン混合物としても用いることが出来る。Tannins (catechol polymers) etc. obtained from cacao etc. are used. These tannins may be unrefined as long as they have a tannin effect (for example, commercially available persimmon tannins may also be used. These tannins can be used alone or as a mixture of one or more tannins.
又、多官能性架橋剤で不溶化させる場合は、前記酵素を
l−λ04bCW/V)の多官能性架橋剤を含有する液
に加え、!〜41Qcでio分〜/A時間反応させ、得
られた酵素沈澱物より例えば遠心分離、濾過等の通常の
分離手段を用いて不溶化酵素を得る。In addition, when insolubilizing with a polyfunctional crosslinking agent, add the enzyme to a solution containing a polyfunctional crosslinking agent of l-λ04bCW/V). The reaction is carried out at ~41Qc for io minutes ~/A hours, and the resulting enzyme precipitate is subjected to conventional separation means such as centrifugation and filtration to obtain an insolubilized enzyme.
なお、多官能性架橋剤としては、ポリアルデヒ)”lA
、(/シアネート類等が適しており1例えばジアルデヒ
ドデンプングリオキザール、マロンアルデヒド、コハク
酸アルデヒド、グルタルアルデヒド、ピメリジアルデヒ
ド、ヘキサメチレンイソシアネー)、p−)ルイレンジ
イソシアネート等が挙げられ、特にグルタルアルデヒド
が望ましい〇そして、酵素を不溶化担体に吸着させる手
段としては1通常の吸着剤1例えば活性炭、シリカゲル
、酸性白土、多孔質ガラス等、又DEAE−セファデッ
クス、 CM−セファデックス、DEAE−セルロース
、 CM−セルロース、アンバーライトIR−り!、ダ
ウエックスー!θ等のイオン交換体等の不溶化担体をカ
ラムに詰めて前記酵素を通液するか、又は該不溶1し担
体を酵素と混合、攪拌して吸着させた後、これを必要に
より例えば遠心分離。In addition, as a polyfunctional crosslinking agent, polyaldehyde
, (/cyanates, etc. are suitable, such as dialdehyde starch glyoxal, malonaldehyde, succinic aldehyde, glutaraldehyde, pimeridialdehyde, hexamethylene isocyanate), p-) lylene diisocyanate, etc., and in particular Glutaraldehyde is preferable. As a means for adsorbing the enzyme to an insolubilizing carrier, 1. Ordinary adsorbents 1. For example, activated carbon, silica gel, acid clay, porous glass, etc., DEAE-Sephadex, CM-Sephadex, DEAE-cellulose. , CM-cellulose, Amberlight IR-ri! , DOWEX! Either an insolubilized carrier such as an ion exchanger such as θ is packed in a column and the enzyme is passed through the column, or the insoluble carrier is mixed with the enzyme, stirred and adsorbed, and then centrifuged, for example, if necessary.
濾過等の分離手段により不溶化担体に吸着した酵素を得
る。なおその後、必要により、該酵素を吸着した不溶化
担体に前記多官能性架橋剤を加えて反応させてもよい。The enzyme adsorbed on the insolubilized carrier is obtained by separation means such as filtration. Thereafter, if necessary, the polyfunctional crosslinking agent may be added to the insolubilized carrier that has adsorbed the enzyme and allowed to react.
次に上記した微生物菌体、酵素をタンニンもしくは多官
能性架橋試薬で不溶化したもの、又は酵素を不溶化担体
に吸着したものを、そのまま、或はこれらを水、または
緩衝液、もしくは親水性有機溶媒に懸濁したものを、水
、または緩衝液、もしくは親水性有機溶媒にゲル基材と
してカラギーナン、寒天、もしくはゼラチンを約70C
以上で加熱溶解した液または該液を適当に冷却した液と
。Next, the above-mentioned microbial cells and enzymes are insolubilized with tannin or a polyfunctional cross-linking reagent, or the enzymes are adsorbed onto an insolubilized carrier, either as they are, or in water, a buffer solution, or a hydrophilic organic solvent. Add carrageenan, agar, or gelatin as a gel base to water, a buffer solution, or a hydrophilic organic solvent at about 70C.
A liquid obtained by heating and dissolving the above liquid or a liquid obtained by appropriately cooling the liquid.
、jj−jjU程度のゲル基材が固化せず、かつ微生物
菌体もしくは酵素が死滅もしくは失活しない温度で混合
してゲル基材が溶解した液を得る。, jj-jjU are mixed at a temperature at which the gel base material is not solidified and the microbial cells or enzymes are not killed or deactivated to obtain a solution in which the gel base material is dissolved.
これに用いる緩衝液としては、例えば酢酸緩衝液、マツ
キルヴエイン緩衝液、リン酸緩衝液、トリス緩衝液、ベ
ロナール緩衝液等が挙げられ、父親水性有機溶媒として
は、メチルアルコール、エチルアルコール、フロビルア
ルコール、アセトン等が挙げられ、これらの有機溶媒は
通常10−λθ係(W/V)程度で用いられる。Buffers used for this purpose include, for example, acetate buffer, pine kilvein buffer, phosphate buffer, Tris buffer, veronal buffer, etc., and examples of aqueous organic solvents include methyl alcohol, ethyl alcohol, flobyl alcohol, etc. , acetone, etc., and these organic solvents are usually used at a ratio of about 10-λθ (W/V).
そしてゲル基材としてのカラギーナン及び寒天は通常O
1j〜3.0係(W/V)程度で、又ゼラチンはg−コ
os(w7v)程度で用いられる。And carrageenan and agar as gel base materials are usually O
The ratio is about 1j to 3.0 (W/V), and gelatin is used at about g-cos (w7v).
次に上記した如くゲル基材を混合し溶解した溶液を、噴
霧器、好ましくは加圧噴霧器を用いて冷却液と噴霧接触
させることにより微小な固定化された微生物菌体もしく
は酵素を得る。Next, a solution obtained by mixing and dissolving the gel base material as described above is sprayed into contact with a cooling liquid using a sprayer, preferably a pressurized sprayer, to obtain minute immobilized microbial cells or enzymes.
これに用いる冷却液としては例えば塩化カリウム、塩化
アンモニウム−塩化アルミニウム笹の索溶液1例えばこ
れらをl−一〇壬(W/V)程度含有した水溶液、オリ
ーブ油、コーン油、パーム油、マツコー鯨頭油、魚油等
の動植物油、スピンドル油、タービン油等の鉱物油、シ
リコーン油。Cooling fluids used for this purpose include, for example, potassium chloride, ammonium chloride-aluminum chloride, bamboo solution 1, an aqueous solution containing about 1-10 mm (W/V) of these, olive oil, corn oil, palm oil, Matsukou whale head. oil, animal and vegetable oils such as fish oil, mineral oils such as spindle oil and turbine oil, and silicone oils.
ボイル油、スタンド油等の合成油、リノール酸。Synthetic oils such as boil oil and stand oil, linoleic acid.
リルイン酸、オレイン酸等の不飽和脂肪酸等が用いられ
、これらをIOC以下に冷却した液が用いられる。Unsaturated fatty acids such as lyluic acid and oleic acid are used, and liquids obtained by cooling these to below IOC are used.
なお、上記ゲル基材としてカラギーナンを用いる場合、
塩1じカリウム、塩化アンモニウム、塩化アルミニウム
等の水溶液の冷却液を用いるのが好ましく、又ゲル基材
として寒天もしくはゼラチンを用いる場合、動植物油、
鉱物油1合成油、不飽和脂肪酸等の冷却液を用いるのが
望ましい0そして固定化された微生物菌体もしくは酵素
を得る際の噴霧接触手段としては、通常加圧噴霧用ノズ
ルを用いて噴霧するのが好ましい0その際。In addition, when using carrageenan as the gel base material,
It is preferable to use a cooling solution of an aqueous solution of potassium salt, ammonium chloride, aluminum chloride, etc. When agar or gelatin is used as the gel base, animal or vegetable oil,
Mineral oil 1 It is preferable to use a cooling liquid such as synthetic oil or unsaturated fatty acids 0 And when obtaining immobilized microbial cells or enzymes, the spray contact means is usually sprayed using a pressurized spray nozzle. Preferably 0 then.
圧力ノズルとしては例えば単純ジェット型ノズル、衝突
ジェット型ノズル、渦巻き型ノズル、2流体型ノズル等
の加圧噴霧ノズルが用いられる0また。As the pressure nozzle, a pressurized spray nozzle such as a simple jet nozzle, an impingement jet nozzle, a swirl nozzle, or a two-fluid nozzle may be used.
回転円板噴霧器もしくは音波、静電気、振動等を利用し
た噴霧器等も用いられる。そして加圧噴霧する場合の噴
霧圧力は’ 、j−A 00 ”j’ / ca ―G
。A rotating disc sprayer or a sprayer using sound waves, static electricity, vibrations, etc. may also be used. And the spray pressure when pressurized spraying is ', j-A 00 "j' / ca - G
.
好ましくは/ −/ユ’ ”t / catΦG程度で
ある。Preferably it is about /-/Y'''t/catΦG.
又、これらの加圧噴霧条件は、使用する菌体及び酵素の
種類、アルギン酸塩の濃度、ノズルの種類等により影響
を受けるので、それにより適宜選択される〇
そして固定化された微生物菌体もしくは酵素のゲル粒子
の大きさは、a常平均粒子径が、最大限goo〜?θ0
ミクロン以下であるが、本発明においては平均粒子径が
to117ミクロン以下となるように調竪することが望
ましく、このような微粒子とすることにより基質との反
応効率を著しく高めることか出来る。In addition, these pressurized spray conditions are affected by the types of microbial cells and enzymes used, the concentration of alginate, the type of nozzle, etc., so they should be selected accordingly. As for the size of the enzyme gel particles, the normal average particle diameter is at most goo~? θ0
In the present invention, it is desirable to adjust the average particle size to 117 microns or less, and by forming such fine particles, the reaction efficiency with the substrate can be significantly increased.
そして、殊に固定11S微生物菌体を上記の如(、!θ
Oミクロン程度以下の微粒子とすれば、例えば該菌体な
用いて発酵させる際、予じめ培養培地で培養することに
より該菌体な増殖させる操作も不要となり、該微生物菌
体を直接発酵に供し得る等の格段に優れた利点を有する
。In particular, the fixed 11S microbial cells were prepared as described above (,!θ
If the particles are of the order of 0 microns or less, for example, when carrying out fermentation using the microbial cells, there is no need to grow the microorganisms by culturing them in a culture medium in advance, and the microorganisms can be used directly for fermentation. It has outstanding advantages such as:
以上の如(、本発明により固定化された微生物菌体もし
くは酵素を用いれば、基質との反応効率を著しく高める
ことが出来、又該酵素を種々の基質に繰り返し使用して
も、該固定化された酵素含有ゲルからの脱離が著しく抑
制される等1本発明は産業上極めて有意義である。As described above, by using microbial cells or enzymes immobilized according to the present invention, the reaction efficiency with substrates can be significantly increased, and even if the enzymes are repeatedly used on various substrates, the immobilization The present invention is of great industrial significance, as the detachment from the enzyme-containing gel is significantly suppressed.
以下、実施例により本発明をさらに具体的に説明する。Hereinafter, the present invention will be explained in more detail with reference to Examples.
実施例 1
タンニン酸〔和光紬薬(株)製〕λノを20m乙の0.
0才Mトリス緩衝液(pH7,0)に溶解したものと、
アスペルギルス・オリゼーFERM P −//ゲタの
皺培養物より硫安分画し、DEAE−セルロースを用い
て精製したロイシン・アミノペプチダーゼ標品ユoom
9をλ0祷のo、ojMトリス緩衝液CpH7,o)に
溶解したものとを充分混合シ、該ロイシン・アミノペプ
チダーゼを不溶1しく沈澱)させた。Example 1 Tannic acid [manufactured by Wako Tsumugi Co., Ltd.]
Dissolved in 0-year-old M Tris buffer (pH 7,0),
Leucine aminopeptidase specimen purified using DEAE-cellulose and ammonium sulfate fractionated from Aspergillus oryzae FERM P-//Geta furrow culture.
The leucine aminopeptidase was thoroughly mixed with a solution of leucine aminopeptidase dissolved in an ojM Tris buffer (CpH 7,0) at λ0, to precipitate the leucine aminopeptidase.
該沈澱物を常法により遠心分離した後、上述のトリス緩
衝i&cpH7,0)で4回洗滌した。The precipitate was centrifuged in a conventional manner, and then washed four times with the above-mentioned Tris buffer i&c (pH 7.0).
得られた不溶1し酵素(乾物量として300m1)に、
/%(W/V)の寒天濃度となるように寒天に水を加え
たものを9ICで加熱溶解し、ついでyscに冷却した
寒天水溶液−〇mbを加えて混合しく混合時の温度:
4t oC)、これをエアーレス−スプレイヤー〔コ流
体型、ノズル口径:0.!陶、噴霧圧力ニ 、7 、
oKy/crA * G、英国バーゲス社製〕でjCに
冷却したコーン油中に加圧噴霧し、平均粒子径100〜
λsoミクロンの微粒子状に固定化されたロイシン・ア
ミノペプチダーゼを得た(実施例1の固定化酵素)。To the obtained insoluble enzyme (300 ml as dry matter),
Agar and water were added to give an agar concentration of /% (W/V) and dissolved by heating at 9 IC, then an agar aqueous solution cooled to ysc - 0 mb was added and mixed. Temperature during mixing:
4t oC), and then use it as an airless sprayer [co-fluid type, nozzle diameter: 0. ! Pottery, spray pressure 2, 7,
oKy/crA*G, manufactured by Burgess, UK] was sprayed under pressure into corn oil cooled to jC, and the average particle size was 100~
Leucine aminopeptidase immobilized in the form of λso micron particles was obtained (immobilized enzyme of Example 1).
実施例1の固定化酵素の活性を、従来法で固定化された
ロイシン・アミノペプチダーゼである対照−1および対
照−2の活性と比較した結果は第1表に示すとおりであ
る。なお、
対照−に上記の不溶化酵素(ロイシン拳アミノペプチダ
ーゼ) J 00m9に71(W/V)の寒天濃度とな
るように寒天に水を加えたものをり5溶液ユ01を加え
て混合しく混合時の温度:<t。Table 1 shows the results of comparing the activity of the immobilized enzyme of Example 1 with the activities of Control-1 and Control-2, which are leucine aminopeptidase immobilized by a conventional method. In addition, as a control, add 5 solutions of the above-mentioned insolubilizing enzyme (leucine aminopeptidase) J00m9 to agar with water to give an agar concentration of 71 (W/V), and mix well. Temperature at: <t.
C)、これを注射器(口径:λran)を用いてSCに
冷却したコーン油中に滴下して得た平均粒子径!祁の球
状に固定化されたロイシン・アミノペプチダーゼであり
。C), the average particle diameter obtained by dropping this into corn oil cooled to SC using a syringe (caliber: λran)! It is a leucine aminopeptidase immobilized in a spherical shape.
対照−2:上記の不溶化酵素(ロイシン・アミノペプチ
ダーゼ)3001ngに/%(W/V)の寒天濃度とな
るように寒天に水を加えたものを9オCで加熱溶解し、
ついで41ICに冷却した寒天水浴液コombを加えて
混合しく混合時の温度ニゲOC)、これを注射器(口径
: / a )を用いてICに冷却したコーン油中に滴
下して得た平均粒子径2論の球状に固定化されたロイシ
ン・アミノペプチダーゼである。Control-2: 3001 ng of the above insolubilizing enzyme (leucine aminopeptidase) was added to agar to give an agar concentration of /% (W/V) and dissolved by heating at 9°C.
Next, add the agar water bath solution omb cooled to 41 IC and mix well (temperature at the time of mixing (Nige OC)), and drop this into the corn oil cooled to IC using a syringe (caliber: /a) to obtain average particles. This is a leucine aminopeptidase immobilized in a spherical shape with two diameters.
また、相対酵素活性の測定試験は、上記の各固定化酵素
(O1λ?)を用いてそれぞれロイシン−p−ニトロア
ニリドを基質として中台の方法〔中台忠信、日本醤油研
究所報告3. 99(/り77年〕〕で測定することに
より行ない、得られた活性値を。Relative enzyme activity was measured using Nakadai's method using each of the above-mentioned immobilized enzymes (O1λ?) and using leucine-p-nitroanilide as a substrate [Tadanobu Nakadai, Japan Soy Sauce Research Institute Report 3. 99 (/ri 77 years)] and the obtained activity value.
した相対#素活性値(嗟)を示したのが第1表である。Table 1 shows the relative #element activity values (嗟).
第1表
第1表より明らかな如(、実施例1の固定化酵素は、対
照の固定1し酵素の何れに比しても著しく酵素活性値の
高いものである0
実施例 2
豚の心臓起源の乳酸脱水素酵素(ベーリンガー社M)/
DOダを0.θ!M酢酸緩衝液(pH7,0)コomb
に溶解し、λ、、+ 1 (W/V )グルタルアルデ
ヒド水浴液を5vrt加え、攪拌しつつコOT):、’
93θ分間反応させ、得られた不溶化酵素を常法により
遠心分離した後、0,03M酢酸緩衝液(pHj))3
oombで洗浄後、不溶化酵素を得た。As is clear from Table 1, the immobilized enzyme of Example 1 has a significantly higher enzyme activity value than any of the control immobilized enzymes.Example 2 Pig heart Origin of lactate dehydrogenase (Boehringer M)/
DO da 0. θ! M acetate buffer (pH 7,0)
Add 5vrt of λ,, + 1 (W/V) glutaraldehyde water bath solution, and add while stirring.
After reacting for 93θ minutes and centrifuging the obtained insolubilized enzyme by a conventional method, it was added to a 0.03M acetate buffer (pHj) 3
After washing with OOMB, an insolubilized enzyme was obtained.
得られた不溶化酵素!O■に0.ojM酢酸緩衝WCp
Hz、t)to祷を加え懸濁した液に、l−2%(W/
V)のゼラチン濃度となるようにゼラチンに水を加えた
ものをgocで加熱溶解し、ついで41ICに冷却した
ゼラチン水浴液J−07718を加えて混合しく混合時
の温度: 37C)、これをワグナ−ハンディ−ベイン
ターW −/ 7 o (λ流体型。The obtained insolubilized enzyme! 0. ojM acetate buffer WCp
Hz, t) to the suspension and add 1-2% (W/
V) Gelatin and water were added to the gelatin concentration and dissolved by heating in GOC, and then gelatin water bath solution J-07718 cooled to 41 IC was added and mixed thoroughly (temperature at the time of mixing: 37 C). - Handy Bainter W - / 7 o (λ fluid type.
ノズルロ径:o、7tra、日本ワグナ−スプレーテッ
クス社↓)でICに冷却したシリコーン油中に噴霧圧力
lλOKp/ci”Gで加圧噴霧し、平均粒子径/J−
17〜λsoミクロンの微粒子状に固定化された乳酸脱
水素酵素を得た(実施例2の固定化酵素)0
実施例2の固定化酵素の活性を、従来法で固定化された
乳酸脱水素酵素の活性と比較した結果は第2表に示すと
おりである。なお、
対照−1:上記の不溶化酵素(乳酸脱水素酵素)tom
gに00−0j酢酸緩衝液(pHj、j ) j O罰
を加えて懸濁した液に、12%(W/V)のゼラチン濃
度となるようにゼラチンに水を加えたものをgOCで加
熱溶解し、ついでlICに冷却したゼラチン水溶液!0
祷を加えて混合しく混合時の温度:、?7C)、これを
注射器(口径:コ■〕を用いてjCに冷却したシリコー
ン油中に滴下して得られる平均粒子径jNIIの球状に
固定化された乳酸脱水素酵素であり、
対照−2二上記の不溶化酵素(乳酸脱水素酵素)toI
ngに0.03MM¥酸緩衝液(pHj、z)s。Nozzle diameter: o, 7tra, sprayed under pressure into silicone oil cooled to IC with Nippon Wagner Spraytex Co., Ltd. ↓) at a spray pressure of 1λOKp/ci”G, average particle size/J-
Obtained lactate dehydrogenase immobilized in the form of fine particles of 17 to λso microns (immobilized enzyme of Example 2) The results of comparison with enzyme activity are shown in Table 2. In addition, control-1: the above-mentioned insolubilizing enzyme (lactate dehydrogenase) tom
To a suspension of 00-0j acetate buffer (pHj, j ) j O in g, water was added to gelatin to give a gelatin concentration of 12% (W/V), and the mixture was heated with gOC. Aqueous gelatin solution dissolved and then cooled to IC! 0
Temperature when mixing: ? 7C) is a spherically immobilized lactate dehydrogenase with an average particle diameter of JNII obtained by dropping this into silicone oil cooled to JC using a syringe (caliber: C). The above insolubilizing enzyme (lactate dehydrogenase) toI
ng to 0.03 MM acid buffer (pHj, z).
mlを加えて懸濁した液に、12%(W/V)のゼラチ
ン濃度となるようにゼラチンに水を加えたものをgoC
で加熱溶解し、ついでljCに冷却したゼラチン水溶液
!θ幅を加えて混合しく混合時の温度:、77C)、こ
れを注射器(口径:im)を用いてJCに冷却したシリ
コーン油中に滴下して祷られる平均粒子径i 、jaの
球状に固定化された乳酸脱水素酵素である。ml of gelatin and water was added to the suspension to give a gelatin concentration of 12% (W/V).
An aqueous gelatin solution that was heated and dissolved in ljC and then cooled to ljC! Add the θ width and mix (temperature during mixing: 77C), drop this into silicone oil cooled to JC using a syringe (caliber: im) and fix it in a spherical shape with an average particle diameter of i, ja. It is a converted lactate dehydrogenase.
また、相対酵素活性の測定試験は、上記の各固定化酵素
(o、2g)を用いてそれぞれピルビン酸を基質として
ストルセンバツハの方法〔ストルセンバツハ、メソッド
−イン・工/チモロジ−9゜47g−2g’g(19b
&)〕で測定することにより行ない、得られた活性値を
、対照−1の標品(酵素活性値; ioo%)と比較し
た相対酵素活性値(%)を示したのが第2表である0第
2 表
第2表より明らかな如く、実施例2の固定化酵素は、対
照の固定4し酵素の何れに比しても著しく酵素活性値の
高いものである0
実施例 3
サイロイドコグl〔富士デグイソン化学(株)製〕iy
とウレアーゼ(タイプ9.シグフ社製〕iooダをo、
o!Mトリス緩衝液(、pH7,0)に加えて混合し、
ICで約1時間攪拌することによりウレアーゼを該サイ
ロイドに吸着させ1次いでこれを常法により遠心分離し
た後、上記ト1ノス緩衝液(PH7,17)で洗滌した
。In addition, the relative enzyme activity measurement test was carried out using each of the above-mentioned immobilized enzymes (o, 2 g) and using pyruvate as a substrate using the Strusenbach method [Strusenbach, Method-in-Engineering/Timology-9゜]. 47g-2g'g (19b
Table 2 shows the relative enzyme activity value (%) compared with the control-1 specimen (enzyme activity value; ioo%). As is clear from Table 2, the immobilized enzyme of Example 2 has a significantly higher enzyme activity value than any of the control immobilized enzymes. [Manufactured by Fuji Deguison Chemical Co., Ltd.] iy
and urease (type 9. manufactured by Sigma) ioo da o,
o! M Tris buffer (pH 7,0) and mix;
Urease was adsorbed to the thyroid by stirring with IC for about 1 hour, which was then centrifuged in a conventional manner, and then washed with the above-mentioned Tonos buffer (PH 7, 17).
得られたサイロイドに吸着した酵素soIngを、12
%(W/V)のゼラチン濃度となるようにゼラチンに水
を加えたものをgOCで加熱溶解し、ついでjOCに冷
却したゼラチン水浴液−〇mAと混合しく混合時の温度
: II 、tC)、これを実施例2で用いたワグナ−
ハンディ−ベインターW−/70でjCに冷却したリノ
ール酸液中に噴霧圧力s 、sKy/crA・Gで加圧
噴霧して平均粒子径750〜300ミクロンの微粒子状
に固定化されたウレアーゼを得た(実施例3の固定化酵
素)0実施例3の固定化酵素の活性を、従来法で固定化
されたウレアーゼである対照の活性と比較した結果は第
3表に示すとおりである。The enzyme soIng adsorbed on the obtained thyroid was
% (W/V) of gelatin concentration was heated and dissolved in gOC, and then mixed with gelatin water bath solution cooled to jOC - 〇mA. Temperature during mixing: II, tC) , which was used in Example 2.
Urease immobilized in the form of fine particles with an average particle size of 750 to 300 microns was obtained by spraying under pressure at a spray pressure of s and sKy/crA・G into a linoleic acid solution cooled to jC using a Handy Vainter W-/70. (Immobilized enzyme of Example 3) The activity of the immobilized enzyme of Example 3 was compared with the activity of a control, which is urease immobilized by a conventional method. The results are shown in Table 3.
なお、対照は、上記のサイロイドに吸着した酵X (ウ
L’7−セ) j Omgを7λ%(W/V)のゼラチ
ン濃度となるようにゼラチンに水を加えたものをgoC
で加熱溶解し、ついでgOCに冷却したゼラチン水溶液
コornbと混合しく混合時の温度:ダIC)、これを
注射器(口径:/w)を用いてICに冷却したリノール
酸液中に滴下して得られる平均粒子径コ omの球状に
固定化されたウレアーゼである。In addition, as a control, goC was prepared by adding water to gelatin so that the gelatin concentration was 7λ% (W/V), containing the enzyme X (UL'7-se)
Then, mix with gelatin aqueous solution cooled to gOC (temperature at the time of mixing: da IC), and drop this into the linoleic acid solution cooled to IC using a syringe (caliber: /w). The resulting urease is immobilized in a spherical shape with an average particle size of 0.
また、相対酵素活性の測定試験は、上記の各固定化酵素
(O2=?〕を用いてそれぞれ尿素を基質としてライセ
ルの方法〔ライセル・エフ・ジエー、ジ・エンチームス
3版、!、7〜コ/(/97/))で測定することによ
り行ない、得られた活性値を、対照の標品(酵素活性値
=IOθ%)と比較した相対酵素活性値(%)を示した
のが第3表である。In addition, relative enzyme activity measurement tests were carried out using each of the above-mentioned immobilized enzymes (O2 = ?) and using urea as a substrate using Lyssel's method [Lyssel F.G., The Enteams 3rd edition,!, 7 to /(/97/)), and the relative enzyme activity value (%) was shown by comparing the obtained activity value with the reference specimen (enzyme activity value = IOθ%). It is a table.
第 3 表
第3表より明らかな如く、実施例3の固定化酵素は対照
の固定化酵素に比し著しく酵素活性値の高いものである
。Table 3 As is clear from Table 3, the immobilized enzyme of Example 3 has a significantly higher enzyme activity value than the control immobilized enzyme.
実施例 4
グルコース2%(W/V)、ペプトン1%(W/V)、
酵母x * ス/ % (W / V ) 、及び食塩
i。Example 4 Glucose 2% (W/V), Peptone 1% (W/V),
yeast x*s/% (W/V), and salt i.
%(W/V)を含む培養培地CpH!、j)t、1を3
にフラスコに入れ、常法により殺菌した後、該培地にザ
ツカロミセス・ルキシーATCC/ 0 、? g J
の種培養液io祷を接種し、30Cで7λ時間振盪培養
した。得られた培養終了液l!を遠心分離して集菌し、
これを凍結乾燥した後、!?の乾燥酵母菌体を得た。Culture medium containing % (W/V) CpH! , j) t, 1 to 3
After putting it in a flask and sterilizing it by a conventional method, the culture medium was injected with Zatsucharomyces luxii ATCC/0, ? g J
The seed culture solution IO was inoculated and cultured with shaking at 30C for 7 hours. Obtained cultured solution l! Centrifuge to collect bacteria,
After freeze-drying this! ? Dry yeast cells were obtained.
得られた酵母菌体!?を、1%(W/V)のカラギーナ
ン濃度となるようにカンバー〇カラギーナンにo、os
Mトリス緩衝液(pH7,O)を加えたものを9DCで
加熱溶解し、ついでグオCに冷却したカラギーナン水溶
液6001jLbと混合しく混合時の温度ニゲO)、こ
れを3!の密閉圧力容器に投入し、これにヘリウムガス
を導入後、該圧力容器内の圧力をlOM/C1/I@G
に調整し1次いでノズル〔匂MKBOIio3g型、ノ
ズルロ径:o、ttm、いけうち(株)製〕のコックを
開け、−3Cに冷却した70%(W/V)塩化カリウム
水浴液中に加圧噴霧して平均粒子径2!0−300ミク
ロンの微粒子状に固定化された酵母菌体を得た(実施例
4の固定化酵母)0
実施例4の固定化酵母のアルコール生産性を従来法で固
定化された酵母菌体である対照−1および対照−2のア
ルコール生産性と比較した結果を第4表に示す。なお。The obtained yeast cells! ? , o, os to Cumber carrageenan to give a carrageenan concentration of 1% (W/V)
M Tris buffer (pH 7, O) was added and dissolved by heating at 9DC, and then mixed with aqueous carrageenan solution 6001jLb cooled to Guo C. After introducing helium gas into the sealed pressure vessel, the pressure inside the pressure vessel is adjusted to lOM/C1/I@G.
Then, open the cock of the nozzle [MKBOIio 3g type, nozzle diameter: o, ttm, manufactured by Ikeuchi Co., Ltd.] and spray under pressure into a 70% (W/V) potassium chloride water bath solution cooled to -3C. to obtain immobilized yeast cells in the form of fine particles with an average particle diameter of 20-300 microns (immobilized yeast of Example 4). Alcohol productivity of the immobilized yeast of Example 4 was determined by the conventional method. Table 4 shows the results of comparing the alcohol productivity of immobilized yeast cells, Control-1 and Control-2. In addition.
対照−1:上記の酵母菌体、5′ノを、7%(W/V)
のカラギーナン濃度となるようにカツノく−・カラギー
ナンにo、oタMトリス緩衝液(pH7,o)を加えた
ものを90Cで加熱溶解し、ついでなΔ′Cに冷却した
カラギーナン水溶g t o o rnbと混合シ(混
合時の温度:+OC)、これを注射器(口径:コ割−)
を用いて一3Cに冷却した70%(W/V)塩化カリウ
ム水溶液中に滴下して得られる平均粒子径5trrrh
−の球状に固定化された酵母菌体であり、
対照−2=上記の酵母菌体!ノを、1%(W/V)のカ
ラギーナン濃度となるようにカツノく−・カラギーナン
にO,Oj”M)リス緩衝液(1)H7−17)を加え
たものを9θCで加熱溶解し、ついで4tjCに冷却し
たカラギーナン水溶液JOOmlと混合しく混合時の温
度:yoC)、これを注射器(口径: / mrh )
を用いて一3C釦冷却したIQ%(W/V)塩化カリウ
ム水浴液中に滴下して得られる平均粒子径−勤−の球状
に固定化された酵母菌体である。Control-1: The above yeast cells, 5', 7% (W/V)
Aqueous carrageenan solution was prepared by heating and dissolving carrageenan with o, o M Tris buffer (pH 7, o) at 90C to give a carrageenan concentration of g to Mix it with o rnb (temperature during mixing: +OC), and use it in a syringe (caliber: Kowari-).
An average particle diameter of 5 trrrh obtained by dropping into a 70% (W/V) potassium chloride aqueous solution cooled to -3C using
− is a yeast cell immobilized in a spherical shape, and Control-2 = the above yeast cell! A mixture of carrageenan and O, Oj''M) Lith buffer (1) H7-17) was added to carrageenan to give a carrageenan concentration of 1% (W/V) and dissolved by heating at 9θC. Next, mix with JOOml of carrageenan aqueous solution cooled to 4tjC (temperature at mixing: yoC), and use a syringe (caliber: / mrh).
Yeast cells are immobilized in a spherical shape with an average particle diameter of 100 ml, which is obtained by dropping them into an IQ% (W/V) potassium chloride water bath solution that has been cooled using a 13C button.
また、アルコール生産性の測定は、グルコースg%(W
/V)、ペプトン1%(W/V)、酵母xキスo 、、
7%(W/V)、及び食塩/g%(W/V)を含む培地
(pHt、a ) i o ombをto。In addition, the measurement of alcohol productivity was performed using glucose g% (W
/V), peptone 1% (W/V), yeast x kiss o,,
7% (W/V) and saline/g% (W/V) (pHt, a) to io omb.
!フラスコに入れ、常法により殺菌した後、該培地に上
記の各固定化酵母(湿潤菌体)!l加え。! After putting it in a flask and sterilizing it by a conventional method, each of the above-mentioned immobilized yeast (wet bacterial cells) was added to the medium! Add l.
夫々の培地で3θC13日間靜置培養した培養液のアル
コール濃度を測定することにより行なった。This was done by measuring the alcohol concentration of the culture solution that was incubated at 3θC for 13 days in each medium.
その結果を第4表に示す。The results are shown in Table 4.
第4表
第4表より明らかな如(、実施例4の固定化酵母を用い
れば、対照の固定化酵母の何れを用いた場合よりもアル
コール生成量は著しく向上することが認められた。As is clear from Table 4, it was found that when the immobilized yeast of Example 4 was used, the amount of alcohol produced was significantly improved compared to when any of the immobilized control yeasts were used.
出願人 キッコーマン株式会社Applicant: Kikkoman Corporation
Claims (1)
橋試薬で不溶化したもの、又は酵素を不溶化担体に吸着
したものを、そのまま、或はこれらを水、または緩衝液
、もしくは親水性有機溶媒に懸濁したものを、水、また
は緩衝液、もしくは親水性有機溶媒にゲル基材としてカ
ラギーナン、寒天、もしくはゼラチンを加熱溶解した液
と、ゲル基材が固化せず、かつ微生物菌体もしくは酵素
が死滅もしくは失活しない温度で混合した液を、冷却液
と噴霧接触させ微小ゲルとすることを特徴とする固定化
された微生物菌体もしくは酵素の製造溶液、塩化アルミ
ニウム水溶液、動植物油、鉱物油1合成油及び不飽和脂
肪酸より選ばれた少なくとも1種i秦迦卓である特許請
求の節囲筬l頂記載の固定化された微生物菌体もしくは
酵素の製造法0 (3) o 、 s〜t、 o oKy/clt *
Gの噴霧圧力で。 加圧噴霧することを特徴とする特許請求の範囲第1項記
載の固定化された微生物菌体もしくは酵素の製造法。 (4)固定化された微生物菌体もしくは酵素のゲル平均
粒子径がtoo ミクロン以下である特許請求の範囲第
1項記載の固定1しされた微生物菌体もしくは酵素の製
造法。 (5)多官能性架橋試薬がグルタルアルデヒドである特
許請求の範囲第1項記載の固定化された微生物菌体もし
くは酵素の製造法0[Scope of Claims] (1) Microbial cells, enzymes insolubilized with tannins or polyfunctional crosslinking reagents, or enzymes adsorbed to insolubilized carriers, as they are, or in water, buffer, Or, if the suspension in a hydrophilic organic solvent is heated and dissolved in water, a buffer solution, or a hydrophilic organic solvent with carrageenan, agar, or gelatin as a gel base material, the gel base material does not solidify, and A manufacturing solution for immobilized microbial cells or enzymes, an aluminum chloride aqueous solution, characterized in that the solution is mixed at a temperature that does not kill or deactivate the microbial cells or enzymes and is sprayed into contact with a cooling liquid to form a microgel. At least one selected from animal and vegetable oils, mineral oils, synthetic oils, and unsaturated fatty acids; A method for producing immobilized microbial cells or enzymes as described in the section of the patent claim 0 (3) ) o, s~t, o oKy/clt *
At a spray pressure of G. The method for producing immobilized microbial cells or enzymes according to claim 1, which comprises pressurized spraying. (4) The method for producing immobilized microbial cells or enzymes according to claim 1, wherein the gel average particle diameter of the immobilized microbial cells or enzymes is not more than too microns. (5) Method 0 for producing immobilized microbial cells or enzymes according to claim 1, wherein the polyfunctional crosslinking reagent is glutaraldehyde.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16516783A JPS6058071A (en) | 1983-09-09 | 1983-09-09 | Preparation of immobilized mold of microorganism or enzyme |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16516783A JPS6058071A (en) | 1983-09-09 | 1983-09-09 | Preparation of immobilized mold of microorganism or enzyme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS6058071A true JPS6058071A (en) | 1985-04-04 |
Family
ID=15807126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16516783A Pending JPS6058071A (en) | 1983-09-09 | 1983-09-09 | Preparation of immobilized mold of microorganism or enzyme |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6058071A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0239885A (en) * | 1988-07-29 | 1990-02-08 | Nok Corp | Production of microorganism-immobilized gel |
-
1983
- 1983-09-09 JP JP16516783A patent/JPS6058071A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0239885A (en) * | 1988-07-29 | 1990-02-08 | Nok Corp | Production of microorganism-immobilized gel |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0320234B2 (en) | ||
| FI68078C (en) | FOERFARANDE FOER FRAMSTAELLNING AV BIOLOGISKT AKTIVA MICROORGANISMMYCELIEPELLETS | |
| US4182655A (en) | Enzyme immobilization with a protein carrier | |
| US4016293A (en) | Method of carrying out enzyme catalyzed reactions | |
| Vojtíšek et al. | Immobilized cells | |
| L'. Kurillova, P. Gemeiner, A. Vikartovska, H. Mikova, M. Rosenberg, M. Ilavsky | Calcium pectate gel beads for cell entrapment. 6. Morphology of stabilized and hardened calcium pectate gel beads with cells for immobilized biotechnology | |
| JP2683524B2 (en) | Immobilization carrier | |
| JPS6058071A (en) | Preparation of immobilized mold of microorganism or enzyme | |
| Bihari et al. | Studies on immobilized fungal spores for microbial transformation of steroids: 11 α‐Hydroxylation of progesterone with immobilized spores of Aspergillus ochraceus G8 on polyacrylamide gel and other matrices | |
| JPS6030684A (en) | Preparation of immobilized microbial cell or enzyme | |
| CN112813048B (en) | Composition used as immobilized lipase coating, preparation method and application thereof | |
| CA1319632C (en) | Method for microbial immobilization | |
| JPS6098985A (en) | Preparation of immobilized mold of microorganism for enzyme | |
| Rahim et al. | Butyl acetate synthesis using immobilized lipase in calcium alginate beads | |
| KR900002839B1 (en) | Composition and method for immobilizing cells and enzymes in a carrier matrix | |
| Rose et al. | Production of isomalt | |
| IE63088B1 (en) | Biocatalysts and processes for the manufacture thereof | |
| JPS6156076A (en) | Immobilized enzyme and its preparation | |
| JPH0371880B2 (en) | ||
| Mohammadzadeh et al. | Synthesis and characterisation of magnetic κ-carrageenan nanocomposites for chitinase33 enzyme immobilisation | |
| JPH06508529A (en) | Method for producing D-amino acid or D-amino acid derivative | |
| SU744002A1 (en) | Method of preparing immobilized enzymes | |
| Hartmeier | Methods of immobilization | |
| JPS6043382A (en) | Immobilized microorganism and its preparation | |
| JPS60221089A (en) | Preparation of immobilized microbial cell or enzyme |